777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)
Migden, Michael R, Chai-Ho, Wanxing, Daniels, Gregory A, Wise-Draper, Trisha M, Kheterpal, Meenal, Tang, Jennifer C, Bolotin, Diana, Verschraegen, Claire, Poklepovic, Andrew S, Khan, Shaheer A, Ibrahim, Sherrif F, Zeitouni, Nathalie C, Medina, Theresa, Tsai, Katy K, Tucci, Chris, Navia, Susan, Donthireddy, Laxminarasimha, Bommareddy, Praveen K, Hou, Jeannie W, Davar, Diwakar
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
705 Biodistribution and shedding analysis following RP1 oncolytic immunotherapy dosing in patients from the IGNYTE clinical trial
Bommareddy, Praveen K, Monteagudo, Alina, Milhem, Mohammed, Sacco, Joseph J, Bowles, Tawnya Lynn, Tsai, Katy K, In, Gino K, Muñoz-Couselo, Eva, VanderWalde, Ari M, Chesney, Jason Alan, Michels, Judith, Samson, Adel, Beasley, Georgia M, Wise-Draper, Trisha M, Schadendorf, Dirk, Mahmoud, Fade, Wong, Michael K, Hong, Walter, Hou, Jeannie W, Clack, Aaron, Coffin, Robert S, Middleton, Mark R, Chmielowski, Bartosz
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Initial efficacy and safety of RP1 + nivolumab in patients with anti–PD-1–failed melanoma from the ongoing phase 1/2 IGNYTE study
Chmielowski, Bartosz, Milhem, Mohammed M., Sacco, Joseph J., Bowles, Tawnya Lynn, Tsai, Katy K., In, Gino Kim, Muñoz-Couselo, Eva, Vanderwalde, Ari M., Chesney, Jason Alan, Michels, Judith, Samson, Adel, Beasley, Georgia, Schadendorf, Dirk, Mahmoud, Fade, Wong, Michael K.K., Wise-Draper, Trisha Michel, Zhu, Junhong, Bommareddy, Praveen, Hou, Jeannie W., Middleton, Mark R.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Abstract CT003: Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ transplant recipients with advanced cutaneous malignancies (ARTACUS)
Migden, Michael R., Chai-Ho, Wanxing, Daniels, Gregory A., Medina, Theresa, Wise-Draper, Trisha M., Kheterpal, Meenal, Tang, Jennifer C., Ibrahim, Sherrif F., Bolotin, Diana, Verschraegen, Claire, Zeitouni, Nathalie C., Tsai, Katy K., Donthireddy, Laxminarasimha, Bommareddy, Praveen K., Hou, Jeannie W., Hong, Walter, Davar, Diwakar
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article